Literature DB >> 18927430

Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain.

Eric S Mullins1, Keith W Kombrinck, Kathryn E Talmage, Maureen A Shaw, David P Witte, Joni M Ullman, Sandra J Degen, William Sun, Matthew J Flick, Jay L Degen.   

Abstract

Mice carrying a conditional prothrombin knockout allele (fII(lox)) were established to develop an experimental setting for exploring the importance of thrombin in the maintenance of vascular integrity, the inflammatory response, and disease processes in adult animals. In the absence of Cre-mediated recombination, homozygous fII(lox/lox) mice or compound heterozygous mice carrying one fII(lox) allele and one constitutive-null allele were viable. Young adults exhibited neither spontaneous bleeding events nor diminished reproductive success. However, the induction of Cre recombinase in fII(lox) mice using the poly I:C-inducible Mx1-Cre system resulted in the rapid and near-complete recombination of the fII(lox) allele within the liver, the loss of circulating prothrombin, and profound derangements in coagulation function. Consistent with the notion that thrombin regulates coagulation and inflammatory pathways, an additional early consequence of reducing prothrombin was impaired antimicrobial function in mice challenged with Staphylococcus aureus peritonitis. However, life expectancy in unchallenged adults genetically depleted of prothrombin was very short ( approximately 5-7 days). The loss of viability was associated with the development of severe hemorrhagic events within multiple tissues, particularly in the heart and brain. Unlike the constitutive loss of either clotting or platelet function alone, the conditional loss of prothrombin is uniformly not compatible with maintenance of hemostasis or long-term survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927430      PMCID: PMC2628376          DOI: 10.1182/blood-2008-07-169003

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  Association between arterial and intracranial pressures.

Authors:  M Czosnyka
Journal:  Br J Neurosurg       Date:  2000-04       Impact factor: 1.596

2.  Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia.

Authors:  N H Gehring; U Frede; G Neu-Yilik; P Hundsdoerfer; B Vetter; M W Hentze; A E Kulozik
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

3.  Participation of protease-activated receptor-1 in thrombin-induced microglial activation.

Authors:  Zhiming Suo; Min Wu; Syed Ameenuddin; Heidi E Anderson; Jamie E Zoloty; Bruce A Citron; Patricia Andrade-Gordon; Barry W Festoff
Journal:  J Neurochem       Date:  2002-02       Impact factor: 5.372

4.  Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction.

Authors:  R Pawlinski; A Fernandes; B Kehrle; B Pedersen; G Parry; J Erlich; R Pyo; D Gutstein; J Zhang; F Castellino; E Melis; P Carmeliet; G Baretton; T Luther; M Taubman; E Rosen; N Mackman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-08       Impact factor: 11.205

5.  Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells.

Authors:  Hiroshi Kataoka; Justin R Hamilton; David D McKemy; Eric Camerer; Yao-Wu Zheng; Abby Cheng; Courtney Griffin; Shaun R Coughlin
Journal:  Blood       Date:  2003-07-17       Impact factor: 22.113

Review 6.  Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: lessons from low tissue factor mice.

Authors:  Rafal Pawlinski; Brian Pedersen; Jonathan Erlich; Nigel Mackman
Journal:  Thromb Haemost       Date:  2004-09       Impact factor: 5.249

7.  Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation.

Authors:  Zhiming Suo; Min Wu; Bruce A Citron; Chenhua Gao; Barry W Festoff
Journal:  J Biol Chem       Date:  2003-05-29       Impact factor: 5.157

8.  Role of fibrinogen- and platelet-mediated hemostasis in mouse embryogenesis and reproduction.

Authors:  J S Palumbo; M Zogg; K E Talmage; J L Degen; H Weiler; B H Isermann
Journal:  J Thromb Haemost       Date:  2004-08       Impact factor: 5.824

9.  Rescue of prothrombin-deficiency by transgene expression in mice.

Authors:  William Y Sun; Mallory J Coleman; David P Witte; Sandra J F Degen
Journal:  Thromb Haemost       Date:  2002-12       Impact factor: 5.249

10.  Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation.

Authors:  Timothy Myles; Toshihiko Nishimura; Thomas H Yun; Mariko Nagashima; John Morser; Andrew J Patterson; Ronald G Pearl; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2003-10-02       Impact factor: 5.157

View more
  26 in total

Review 1.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

2.  A combined deficiency of tissue factor and PAR-4 is associated with fatal pulmonary hemorrhage in mice.

Authors:  Michael F Bode; Nigel Mackman
Journal:  Thromb Res       Date:  2016-08-22       Impact factor: 3.944

3.  Protective and detrimental effects of neuroectodermal cell-derived tissue factor in mouse models of stroke.

Authors:  Shaobin Wang; Brandi Reeves; Erica M Sparkenbaugh; Janice Russell; Zbigniew Soltys; Hua Zhang; James E Faber; Nigel S Key; Daniel Kirchhofer; D Neil Granger; Nigel Mackman; Rafal Pawlinski
Journal:  JCI Insight       Date:  2016-07-21

4.  Role of the coagulation system in the pathogenesis of sickle cell disease.

Authors:  Md Nasimuzzaman; Punam Malik
Journal:  Blood Adv       Date:  2019-10-22

5.  Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion.

Authors:  Yi Yang; Amanda Stang; Patrick G Schweickert; Nadia A Lanman; Erin N Paul; Brett P Monia; Alexey S Revenko; Joseph S Palumbo; Eric S Mullins; Bennett D Elzey; Edith M Janssen; Stephen F Konieczny; Matthew J Flick
Journal:  Cancer Res       Date:  2019-05-02       Impact factor: 12.701

6.  Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture.

Authors:  Zhi Xu; Francis J Castellino; Victoria A Ploplis
Journal:  Blood       Date:  2009-12-15       Impact factor: 22.113

7.  Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.

Authors:  Rikke Stagaard; Carsten Dan Ley; Kasper Almholt; Lisbeth Høier Olsen; Tom Knudsen; Matthew J Flick
Journal:  Blood Adv       Date:  2018-11-27

8.  Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.

Authors:  Paritha I Arumugam; Eric S Mullins; Shiva Kumar Shanmukhappa; Brett P Monia; Anastacia Loberg; Maureen A Shaw; Tilat Rizvi; Janaka Wansapura; Jay L Degen; Punam Malik
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113

9.  Proteolysis of human thrombin generates novel host defense peptides.

Authors:  Praveen Papareddy; Victoria Rydengård; Mukesh Pasupuleti; Björn Walse; Matthias Mörgelin; Anna Chalupka; Martin Malmsten; Artur Schmidtchen
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

10.  Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense.

Authors:  Joni M Prasad; Oleg V Gorkun; Harini Raghu; Sherry Thornton; Eric S Mullins; Joseph S Palumbo; Ya-Ping Ko; Magnus Höök; Tovo David; Shaun R Coughlin; Jay L Degen; Matthew J Flick
Journal:  Blood       Date:  2015-07-30       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.